Pillstats
Rx only · Solution, Concentrate · Oral

Cromolyn Sodium

Cromolyn Sodium

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA07EB01
RxCUI (US)42612
US makers3 labelers
Packages3
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.097$0.193$0.290$0.387Mar 2026May 2026Jul 2026
$0.314
Latest avg · Jul 22, 2026
-5%
Since Mar 18, 2026
3
Active US suppliers
67%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.2K6.5K9.7K13K2025 Q12025 Q22025 Q32025 Q42026 Q1
11K
Rx · 2026 Q1
9.5M
Units dispensed
+86%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Omnivium Pharmaceuticals LLCunknown1SUPPLYING
Micro Labs Limitedunknown1SUPPLYING
Rising Pharma Holdings, Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Nov 3, 2023
    SHORTAGEDrug shortage: Cromolyn Sodium Concentrate (Micro Labs LTD)

    Cromolyn Sodium Concentrate — reported in shortage by Micro Labs LTD. Therapeutic category: Pulmonary/Allergy.

  • Nov 3, 2023
    SHORTAGEDrug shortage: Cromolyn Sodium Concentrate (Rising Pharma Holdings, Inc.)

    Cromolyn Sodium Concentrate — reported in shortage by Rising Pharma Holdings, Inc.. Therapeutic category: Pulmonary/Allergy.